Your Dose of Cannabis Education
Your Dose of Cannabis Education
Only have a minute but want to Learn something every day™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.
Your Dose of Cannabis Education is based on data from the studies and reviews published in the current peer-reviewed medical journals. Whether you are a healthcare provider, patient, caregiver, an individual working in the healthcare sector, or just a curious person, you can benefit from Your Dose of Cannabis Education.
Wake up every morning and get your dose of unbiased evidence-based cannabis education!
Share:
2026-03-18
On April 6, 2020, the DEA removed Epidiolex (an FDA-approved CBD product) from Schedule V and de-scheduled it entirely. How does the descheduling impact the prescribing of this CBD product? 
The descheduling means that Epidiolex is no longer subject to the Controlled Substances Act and its tracking and monitoring requirements. In other words, prescriptions for Epidiolex, like other non-controlled medicines, will be valid for one year and can be easily transferred between pharmacies. The de-scheduling of Epidiolex also enables physicians to prescribe this breakthrough medicine free of the requirements of state prescription drug monitoring programs.GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance
https://www.globenewswire.com/news-release/2020/04/06/2012160/0/en/GW-Pharmaceuticals-plc-and-Its-U-S-Subsidiary-Greenwich-Biosciences-Inc-Announce-That-EPIDIOLEX-cannabidiol-Oral-Solution-Has-Been-Descheduled-And-Is-No-Longer-A-Controlled-Substan.html
2026-03-17
Is delta-9-THC a more potent anti-inflammatory than aspirin? Than hydrocortisone?
"The research in this area indicates that delta-9-THC (a partial agonist of the CB1 receptor) has anti-inflammatory activity resulting from the inhibition of prostaglandin E2 (PGE2) synthesis, the reduction of platelet aggregation, and the stimulation of lipoxygenase... delta-9-THC has 20 times the anti-inflammatory potency of aspirin and twice that of hydrocortisone, but in contrast to all NSAIDs, it does not inhibit cyclooxygenase (COX) at physiological concentrations."Rodríguez Mesa XM, Moreno Vergara AF, Contreras Bolaños LA, Guevara Moriones N, Mejía Piñeros AL, Santander González SP. Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases. Cannabis Cannabinoid Res. 2021 Jun;6(3):196-210. doi: 10.1089/can.2020.0183. Epub 2021 May
2026-03-16
Have any studies compared chronic pain patients' scheduling of THC administration to that of CBD administration?
According to a survey involving 1087 adults with chronic pain, "THC-rich products were typically used at night, while CBD-rich products were more often used during the day."Boehnke KF, Yakas L, Scott JR, DeJonckheere M, Litinas E, Sisley S, Clauw DJ, Williams DA, McAfee J. A mixed methods analysis of cannabis use routines for chronic pain management. J Cannabis Res. 2022 Jan 11;4(1):7.
2026-03-13
Have any studies found that some modes of cannabinoid administration are more effective than others for the treatment of pain?
According to a survey involving 1087 adults with chronic pain, "participants using non-inhalation + inhalation administration routes reported larger improvements in health than the non-inhalation... and inhalation subgroups. Similarly, the non-inhalation + inhalation group had significantly more medication substitutions than those using just non-inhalation.... and inhalation administration routes, respectively."Boehnke KF, Yakas L, Scott JR, DeJonckheere M, Litinas E, Sisley S, Clauw DJ, Williams DA, McAfee J. A mixed methods analysis of cannabis use routines for chronic pain management. J Cannabis Res. 2022 Jan 11;4(1):7.
2026-03-12
Which cannabinoid administration routine for the treatment of chronic pain is most often employed... non-inhalation, inhalation or a combination of both?
According to a survey involving just over 1000 adults with chronic pain using cannabis for symptom management in the USA and Canada, 18.8%, 36.2%, and 45% used non-inhalation, inhalation, and non-inhalation + inhalation routes, respectively. Those who used inhalation routes were younger, while a higher proportion of those who used non-inhalation routes were female." Boehnke KF, Yakas L, Scott JR, DeJonckheere M, Litinas E, Sisley S, Clauw DJ, Williams DA, McAfee J. A mixed methods analysis of cannabis use routines for chronic pain management. J Cannabis Res. 2022 Jan 11;4(1):7.
Learn something every day™ in your 
feed…
Our courses
CBD in Clinical Care V2
A Nationally Approved CME/CE Medical Marijuana Course V2
Cannabis Essentials CME/CE Bundle
New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for “Your Dose of Cannabis Education” emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.